STOCK TITAN
  1. Home
  2. News
  3. USNA
  4. USANA Health Sciences Reports First Quarter Results

USANA Health Sciences Reports First Quarter Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 3, 2021.

Key Financial & Operating Highlights

  • First quarter net sales increased 15.5% year-over-year to $308.0 million.
  • First quarter diluted EPS increased 17.9% year-over-year to $1.45.
  • Repurchased 721,000 shares for $69.5 million during the quarter.
  • Raises 2021 net sales and diluted EPS outlook.

Q1 2021 Financial Performance

Consolidated Results

Net Sales

$308.0 million

  • +15.5% vs. prior-year quarter
  • +9.3% constant currency vs. prior-year quarter
  • +$16.6 million YOY FX impact, or +6.2%

Diluted EPS

$1.45

  • +17.9% vs. prior-year quarter
  • Diluted shares of 21.1 million, -2.1%

Active Customers

617,000

  • +7.7% vs. prior-year quarter

“We had an excellent start to the year largely due to continued strong consumer demand for our high-quality products,” said Kevin Guest, Chief Executive Officer and Chairman of the Board. “Our strong top-line performance was driven by double-digit year-over-year sales growth in each of our regions, and we expect the execution of our 2021 global growth strategy will continue to generate growth in the remainder of the year.”

Q1 2021 Regional Results:

Asia Pacific Region

Net Sales

$251.3 million

  • +16.6% vs. prior-year quarter
  • Constant currency net sales: +9.3%
  • 81.6% of consolidated net sales

Active Customers

472,000

  • +5.1% vs. prior-year quarter

Asia Pacific Sub-Regions

Greater China

Net Sales

$149.0 million

  • +13.3% vs. prior-year quarter
  • Constant currency net sales: +5.9%

Active Customers

276,000

  • -0.4% vs. prior-year quarter
  • +9.5% sequentially

North Asia

Net Sales

$30.2 million